Empros Pharma AB

Suède

Commandez votre montre hebdomadaire Empros Pharma AB
Quantité totale PI 11
Rang # Quantité totale PI 142 146
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 085
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

5 0
1 0
4 0
1
 
Dernier brevet 2025 - Reduced rebound effects in subje...
Premier brevet 2015 - Modified release composition of ...
Dernière marque 2023 - EMPROS
Première marque 2023 - EMPROS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Modified release composition of orlistat and acarbose for the treatment of obesity and related me...
2023 P/S Pharmaceutical preparations and substances; Pharmaceutical preparations, namely, pharmaceutical p...
2022 Invention Reduced rebound effects in subjects treated for overweight or obesity. The present invention rel...
Invention Synergistic effects on weight loss, improved quality of life and reduced gastro-intestinal side e...
Invention Use of a composition comprising orlistat and acarbose to obtain a sustained weight loss. The pres...
Invention Synergistic effects on weight loss, improved quality of life and gastro-intestinal side effects w...
Invention Reduced rebound effects in subjects treated for overweight or obesity. The present invention rela...
2015 Invention A modified release composition of orlistat and acarbose for the treatment of obesity and related ...